Last reviewed · How we verify
Sevofluorane
At a glance
| Generic name | Sevofluorane |
|---|---|
| Also known as | Sevorane, SEVO, Sevoflurane Combined Anesthesia |
| Sponsor | Mustafa Kemal University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Impact of Anesthetics on FLIP (NA)
- Effect of Combined Intravenous-Inhalational Anesthesia (CIVIA) on Postoperative Recovery Patterns. (PHASE4)
- Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis (PHASE4)
- Effectivity Gas Extraction to Prevent Anesthesiologists Waste Gas Exposure of Sevofluorane During Pediatric Induction
- Tolerance to Sevoflurane in Children Undergoing Repeated Drug Exposure
- Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies (NA)
- Sevoflurane Protective Effect on Ischemia Reperfusion Injury in Microvascular Surgery (NA)
- Preconditioning With Sevoflurane and Propofol in Patients Undergoing Minimally Invasive Mitral Valve Surgery
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sevofluorane CI brief — competitive landscape report
- Sevofluorane updates RSS · CI watch RSS
- Mustafa Kemal University portfolio CI